Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods and pharmaceutical compositions useful for treating psoriasis

a technology of psoriasis and composition, applied in the direction of biocide, plant growth regulator, plant ingredients, etc., can solve the problems of limited use of psoriasis treatment agents and practical problems of applying such topical formulations to patients

Inactive Publication Date: 2012-08-16
S U L V E +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, depending on the affected area, applying such topical formulations represent a practical problem for the treated patients, especially during the day.
However, the use of such agents in the treatment of psoriasis is limited by severe side effects and the significant potential of nephrotoxicity, hypertension and liver toxicity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and pharmaceutical compositions useful for treating psoriasis
  • Methods and pharmaceutical compositions useful for treating psoriasis
  • Methods and pharmaceutical compositions useful for treating psoriasis

Examples

Experimental program
Comparison scheme
Effect test

example 1

Plant Seed Extract Containing 4-(Methylthio) Butylisthiocyanate is Capable of Treating Psoriasis Lesions

[0191]A novel composition useful for treating psoriasis lesions was identified by the present inventor, as follows.

[0192]Materials and Experimental Methods

[0193]Eruca Sativa plant extract—An alcoholic extract made from the ripe seeds of rocket (Eruca Sativa Miller) plant (at a 1:1 ratio) was purchased from The Herbal Apothecary (Syston Leicester, England).

[0194]Preparation of an Eruca Sativa plant extract cream—The alcoholic plant extract of E. Sativa was mixed at a 15% final concentration with a base cream to form an emulsion (Base cream Batch No. 50402, C.T.R. Tel Aviv, Israel). The cream was water base to avoid the use of fatty acids which tend to relieve the dryness characterizing the psoriasis lesions.

[0195]Study subjects and application of cream—Psoriasis patients suffering from various degrees of psoriasis lesions participated in the study. Application of the Eruca Sativa p...

example 2

Enzymatic Preparation of 4-Methyl-Thio-Butyl-Isothiocyanate from Glucoerucin Enriched Extract of Eruca Sativa

[0204]To efficiently treat psoriasis, the present inventor further isolated the 4-methyl-thio-butyl-isothiocyanate from an enriched fraction of glucoerucin extract prepared from the ripe seeds of rocket (Eruca sativa), as follows.

[0205]Materials and Experimental Methods

[0206]Extraction of glucoerucin from the ripe seeds of rocket (Eruca sativa)—To extract glucoerucin from the ripe seeds of rocket (Eruca sativa), 1 gram of seeds was heated for 24 hours at 100° C., homogenized for 5 minutes in 70% ethanol, following which the homogenate was heated for 30 minutes at 70° C., cooled down to room temperature and centrifuged for 15 minutes at 17000 g. The ethanol from the obtained supernatant was evaporated and after partial evaporation the remaining water fraction was filtered using 0.2 / 0.45 filter. The presence of glucoerucin was identified using HPLC(HP 1100) connected to UV / VIS...

example 3

Cytotoxicity Effects of 4-Methyl-Thio-Butyl-Isothiocyanate (MTBITC) on Hyperproliferative Cells

[0213]The present inventor further determined the effect of the glucoerucin hydrolysis products which contain 4-methyl-thio-butyl-isothiocyanate on the proliferation of normal or hyperproliferative cells, as follow.

[0214]Materials and Experimental Methods—

[0215]Cell lines—The human keratinocyte cell line [HaCaT; (Boukamp et al 1988 The Journal of cell biology 106:761-771] are considered immortal, reveal a heteroploid stemline with specific stable marker chromosomes, but are not tumorigenic. They have a remarkable capacity for normal differentiation and thus offer a suitable and stable model for studying keratinocyte cells. The Jurkat T-leukemia cells are leukemia cells known to be affected in their cell-cycle progression and apoptosis induction by 4-(methylthio)butylisothiocyanate (Fimognari et al., 2004 Investigational New Drugs 22:119-129).

[0216]Cell culture conditions—HaCaT cells were c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
time periodaaaaaaaaaa
concentrationsaaaaaaaaaa
Login to View More

Abstract

Pharmaceutical or cosmetic compositions including cruciferous plant extract or isothiocyanates such as 4-methyl-thio-butyl-isothiocyanate which are useful for treating psoriasis are provided.

Description

RELATED APPLICATION / S[0001]This application is a divisional of U.S. patent application Ser. No. 11 / 794,926 filed on Jul. 9, 2007, which is a National Phase of PCT Patent Application No. PCT / IL2006 / 000055 having International filing date of Jan. 12, 2006, which claims the benefit of priority of U.S. Provisional Patent Application No. 60 / 642,974 filed on Jan. 12, 2005.[0002]The contents of all of the above applications are incorporated by reference as if fully set forth herein.FIELD AND BACKGROUND OF THE INVENTION[0003]The present invention relates to pharmaceutical compositions useful for treating psoriasis and, more particularly, to a cruciferous plant extract and / or isothiocyanates which are capable of treating psoriasis lesions.[0004]Psoriasis is a common, non-contagious, chronic skin disease affecting 2-4% of the Caucasian population. The main characteristics of the disease include the appearance of thick red zones of the skin covered by silvery or whitish scaled eruptions and pl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/26A61P17/06
CPCA61K31/21A61K36/31A61K31/26A61P17/00A61P17/06
Inventor SUSSAN, IHABSUSSAN, HABIB
Owner S U L V E
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com